Prepsychotic phase of schizophrenia and related disorders: Recent progress and future opportunities

British Journal of Psychiatry

Volumn 187, Issue SUPPL. 48, 2005, Pages

  Phillips, Lisa J ^a,e   McGorry, Patrick D ^a   Yung, Alison R ^a   McGlashan, Thomas H ^b   Cornblatt, Barbara ^c   Klosterkötter, Joachim ^d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b YALE UNIVERSITY   (United States)

^c New York High Risk Project to the Hillside Recognition and Prevention Program   (United States)

^d UNIVERSITY OF COLOGNE   (Germany)

^e ORYGEN RESEARCH CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR; ESTROGEN; GLYCINE; HORMONE RECEPTOR STIMULATING AGENT; ICOSAPENTAENOIC ACID; LITHIUM; NEUROLEPTIC AGENT; NEUROPROTECTIVE AGENT; OLANZAPINE; PLACEBO; RISPERIDONE;

BEHAVIOR THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG MECHANISM; FAMILY COUNSELING; FAMILY HISTORY; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; MENTAL HEALTH; NEUROPROTECTION; PSYCHOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCHIZOPHRENIA; ADOLESCENT; ADULT; ARTICLE; FEMALE; MALE; MENTAL HEALTH SERVICE; ORGANIZATION AND MANAGEMENT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA;

EID: 23744492736     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.187.48.s33     Document Type: Conference Paper

References (94)

1. Bechdolf, A., Wagner, M. & Hambrecht, M. (2002) Psychological intervention in the pre-psychotic phase: preliminary results of a multicentre trial. Acta Psychiatrica Scandinavica, 106, 41.
2. Bell, R. Q. (1992) Multiple-risk cohorts and segmenting risk as solutions to the problem of false positives in risk for the major psychoses. Psychiatry, 55, 370-381.
3. Bentall, R. P. & Morrison, A. P. (2002) More harm than good: the case against using antipsychotic drugs to prevent severe mental illness. Journal of Mental Health, 11, 351-356.
4. Berger, G. E., Wood, S. & McGorry, P. D. (2003) Incipient neurovulnerability and neuroprotection in early psychosis. Psychopharmacology Bulletin, 37, 79-101.
5. Brewer, W. J., Edwards, J., Anderson, V., et al (1996) Neuropsychological, olfactory, and hygiene deficits in men with negative symptom schizophrenia. Biological Psychiatry, 40, 1021-1031.
6. Brewer, W. J., Pantelis, C., Anderson, V., et al (2001) Stability of olfactory identification deficits in neuroleptic-naive patients with first episode psychosis. American Journal of Psychiatry, 158, 107-115.
7. Brewer, W. J., Wood, S. J., McGorry, P. D., et al (2003) Impairment of olfactory identification ability in individuals at ultra high risk for psychosis who later develop schizophrenia. American Journal of Psychiatry, 160, 1790-1794.
8. Brewer, W. J., Francey, S., Wood, S. J., et al (2005) Memory impairments identified in people at ultra high-risk for psychosis who later develop first episode psychosis. American Journal of Psychiatry, 162, 71-78.
9. Cadenhead, K. (2002) Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics and the identification of the schizophrenia prodrome. Psychiatric Clinics of North America, 25, 837-853.
10. Cannon, T. D. & Mednick, S. A. (1993) The schizophrenia high-risk project in Copenhagen: three decades of progress. Acta Psychiatrica Scandinavica, 87 (suppl. 370), s33-s47.
11. Carr, V., Halpin, S., Lau, N., et al (2000) A risk factor screening and assessment protocol for schizophrenia and related psychosis. Australian and New Zealand Journal of Psychiatry, 34 (suppl.), s170-s180.
12. Corcoran, C., Walker, E., Huot, R., et al (2003) The stress cascade and schizophrenia: etiology and onset. Schizophrenia Bulletin, 29, 671-692.
13. Cornblatt, B. A. (2002) The New York High Risk Project to the Hillside Recognition and Prevention (RAP) Program. American Journal of Medical Genetics (Neuropsychiatric Genetics), 114, 956-966.
14. Cornblatt, B. A., Risch, N. J., Faris, G., et al (1988) The Continuous Performance Test, identical Pairs version (CPT-IP): new findings about sustained attention in normal families. Psychiatry Research, 26, 223-238.
15. Cornblatt, B., Lencz, T., Correll, C., et al (2002) Treating the prodrome: naturalistic findings from the RAP Program. Acta Psychiatrica Scandinavica. Supplementum, 106, 44.
16. DeGrazia, D. (2001) Ethical issues in early-intervention clinical trials involving minors at risk for schizophrenia. Schizophrenia Research, 51, 77-86.
17. Eaton, W. W. (1995) Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. American Journal of Psychiatry, 152, 967-972.
18. Edwards, J. & McGorry, P. D. (2002) Implementing Early Intervention in Psychosis: A Guide to Establishing Early Psychosis Services. London: Martin Dunitz.
19. Erlenmeyer-Kimling, L., Squires-Wheeler, E., Adamo, U. H., et al (1995) The New York High Risk project: psychosis and cluster A personality disorders in offspring of schizophrenic parents at 23 years of follow-up. Archives of General Psychiatry, 52, 857-865.
20. Erlenmeyer-Kimling, L., Adamo, U. H., Rock, D., et al (1997) The New York High Risk Project: prevalence and comorbidity of Axis I disorders in offspring of schizophrenic parents at 25-year follow-up. Archives of General Psychiatry, 54, 1096-1102.
21. Falloon, I. R. H., Krekorian, H., Shanahan, W. J., et al (1990) The Buckingham project: a comprehensive mental health service based upon behavioural psychotherapy. Behaviour Change, 7, 51-57.
22. Fava, G. A., Grandi, S., Canestrari, R., et al (1990) Prodromal symptoms in primary major depressive disorder. Journal of Affective Disorders, 19, 149-152.
23. Fenton, W. S., Hibbeln, J. & Knable, M. (2000) Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biological Psychiatry, 47, 8-21.
24. Francey, S. M. (2002) Predicting Psychosis: A Longitudinal Investigation of Prodromal Features and Neurocognitive Vulnerability in Young People at Risk of Psychosis. PhD Thesis. Melbourne, Australia: University of Melbourne.
25. French, P. (2002) Model-driven psychological intervention to prevent onset of psychosis. Acta Psychiatrica Scandinavica. Supplementum, 106, 18.
26. French, P. & Morrison, A. P. (2004) Early detection and cognitive therapy for people at high risk of developing psychosis. New York: John Wiley.
27. Gross, G., Huber, G., Klosterkötter, J. & Linz, M. (1987) Bonner Skala für die Beurteilung von Basissymptomen (BSABS; Bonn Scale for the Assessment of Basic Symptoms). Berlin: Springer.
28. Häfner, H., Maurer, K., Löffler, W., et al (1993) The influence of age and sex on the onset and early course of schizophrenia. British Journal of Psychiatry, 162, 80-86.
29. Häfner, H., Maurer, K., Löffler, W., et al (1994) The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. British Journal of Psychiatry, 164 (suppl. 23), 29-38.
30. Häfner, H., Maurer, K., Löffler, W., et al (1995) Onset and early course of schizophrenia. In Causes of Schizophrenia (eds H. Häfner & W. F. Gattaz), Vol. III, pp. 43-66. New York: Springer.
31. Häfner, H., Löffler, W., Maurer, K., et al (1999) Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatrica Scandinavica, 100, 105-118.
32. Häfner, H., Maurer, K., Löffler, W., et al (2002) The early course of schizophrenia. In Risk and Protective Factors in Schizophrenia: Towards a Conceptual Model of the Disease Process (ed. H. Häfner), pp. 207-228. Darmstadt: Steinkopff.
33. Hambrecht, M., Lammertink, M., Klosterkötter, J., et al (2002) Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic. British Journal of Psychiatry, 181 (suppl. 43), s30-s37.
34. Hawkins, K. A., Addington, J., Keefe, R. S. E., et al (2004) Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophrenia Research, 67, 115-122.
35. Heinrichs, R.W. & Zakzanis, K. K. (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology, 12, 426-445.
36. Heinssen, R., Perkins, D. O., Appelbaum, P. S., et al (2001) Informed consent in early psychosis research: National Institute of Mental Health Workshop, November 15, 2000. Schizophrenia Bulletin, 27, 571-584.
37. Huber, G., Gross, G. & Schüttler, R. (1979) Schizophrenie. Verlaufs- und sozialpsythiatrische Langzeftuntersuchungen an den 1945-1959 in Bonn hospitalisierten schizophrenen Kranken. Bonn: Springer.
38. Javitt, D. C., Silipo, G., Cienfuegos, A., et al (2001) Adjunctive high-dose glycine in the treatment of schizophrenia. International Journal of Neuropsychopharmacology, 4, 385-391.
39. Johannessen, J. O., McGlashan, T. H., Larsen, T. K., et al (2001) Early detection strategies for untreated first-episode psychosis. Schizophrenia Research, 51, 39-46.
40. Johns, L., Broome, M., Matthiasson, P., et al (2002) OASIS: a new service for people with prodromal signs of psychosis. Acta Psychiatrica Scandinavica, 106, 73.
41. Jones, P., Rodgers, B., Murray, R., et al (1994) Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet. 344, 1398-1402.
42. Kay, S. R., Fiszbein, A. & Opler, L. A. (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-269.
43. Klosterkötter, J., Hellmich, M., Steinmeyer, E. M., et al (2001) Diagnosing schizophrenia in the initial prodromal phase. Archives of General Psychiatry, 58, 158-164.
44. Kulkarni, J., Riedel, A., de Castella, A. R., et al (2001) Estrogen: a potential treatment for schizophrenia. Schizophrenia Research, 48, 137-144.
45. Kulkarni, J., Riedel, A., de Castella, A. R., et al (2002) A clinical trial of adjunctive oestrogen treatment in women with schizophrenia. Archives of Women's Mental Health, 5, 99-104.
46. Larsen, T. K. (2002) The transition from the premorbid period to psychosis: how can it be described? Acta Psychiatrica Scandinavica. Supplementum, 106, 10-11.
47. Lencz, T., Smith, C.W., Auther, A., et al (2003) The assessment of 'prodromal schizophrenia": Unresolved issues and future directions. Schizophrenia Bulletin, 29, 717-728.
48. Malla, A. A. & Norman, R. M. G. (2002) Early intervention in schizophrenia and related disorders: advantages and pitfalls. Current Opinion in Psychiatry, 15, 17-23.
49. Manji, H. K., Moore, G. J. & Chen, G. (1999) Lithium at 50: have the neuroprotective effects of this unique cation been overlooked? Biological Psychiatry, 46, 929-940.
50. Mason, O., Startup, M., Halpin, S., et al (2004) Risk factors for transition to first episode psychosis among individuals with at-risk mental states. Schizophrenia Bulletin, 71, 227-237.
51. McFarlane, W. R., Cook, W. L., Robbins, D., et al (2002) Portland identification and early referral. Acta Psychiatrica Scandinavica, 413, 20.
52. McGlashan, T. M. (2001) Psychosis treatment prior to psychosis onset: ethical issues. Schizophrenia Research, 51, 47-54.
53. McGlashan, T. H., Zipursky, R. B., Perkins, D., et al (2003) The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: I. Study rationale and design. Schizophrenia Research, 61, 7-18.
54. McGorry, P. D. (1993) Early Psychosis Prevention and Intervention Centre. Australian Psychiatry, 1, 32-34.
55. McGorry, P. D., Edwards, J., Mihatopolous, C., et al (1996) EPPIC: an evolving system of early detection and optimal management. Schizophrenia Bulletin, 22, 305-326.
56. McGorry, P. D., Yung, A. R. & Phillips, L. J. (2001a) 'Closing in': what features predict the onset of first episode psychosis within a high risk group? In The Early Stages of Schizophrenia (eds R. B. Zipursky & S. C. Schulz), pp. 3-32. Washington, DC: American Psychiatric Press.
57. McGorry, P. D., Yung, A. R. & Phillips, L. J. (2001b) Ethics and early intervention in psychosis: keeping up the pace and staying in step. Schizophrenia Research, 51, 17-29.
58. McGorry, P. D., Yung, A. R., Phillips, L. J., et al (2002) A randomized controlled trial of interventions designed to reduce the risk of progression to first episode psychosis in a clinical sample with subthreshold symptoms. Archives of General Psychiatry, 59, 921-928.
59. Miller, T. J., McGlashan, T. H., Woods, S.W., et al (1999) Symptom assessment in schizophrenic prodromal states. Psychiatric Quarterly, 70, 273-287.
60. Miller, T. J., McGlashan, T. H., Rosen, J. L., et al (2002) Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Symptoms: preliminary evidence of interrater and predictive validity. American Journal of Psychiatry, 159, 863-865.
61. Miller, T. J., Zipursky, R. B., Perkins, D., et al (2003) The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis: II. Baseline characteristics of the "prodromal" sample. Schizophrenia Research, 61, 19-30.
62. Moberg, P. J., Doty, R. L., Turetsky, B. I., et al (1997) Olfactory identification deficits in schizophrenia: correlation with duration of illness. American Journal of Psychiatry, 154, 1016-1018.
63. Mojabai, R., Malaspina, D. & Susser, E. (2003) The promise of primary prevention in schizophrenia: concepts and assumptions. Schizophrenia Bulletin, 29, 791-801.
64. Møller, P. & Husby, R. (2000) The initial prodrome in schizophrenia: searching for naturalistic core dimensions of experience and behavior. Schizophrenia Bulletin, 26, 217-232.
65. Morrison, A. P., French, P., Walford, L., et al (2004) A randomised controlled trial of cognitive therapy for prevention of psychosis in people at ultra-high risk. Schizophrenia Research, 67 (suppl.), 7.
66. Morrison, A. P., Bentall, R. P., French, P., et al (2002) Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors. British Journal of Psychiatry, 181 (suppl. 43), s78-s84.
67. Mrazek, P. J. & Haggarty, R. J. (1994) Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research. Washington, DC: National Academy Press.
68. Norman, R. M. & Malla, A. K. (2001) Duration of untreated psychosis: a critical examination of the concept and its importance. Psychological Medicine, 31, 381-400.
69. Pantelis, C., Velakouis, D., McGorry, P. D., et al (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI study. Lancet, 361, 281-288.
70. Peters, E. (2001) Are delusions on a continuum? The case of religious and delusional beliefs. In Psychosis and Spirituality: Exploring the New Frontier (ed. I. Clarke), pp. 191-207. London: Whurr.
71. Peters, E. R., Joseph, S. A. & Garrety, P. A. (1999) Measurement of delusional ideation in the normal population: introduction the PDI (Peters et al. Delusions Inventory). Schizophrenia Bulletin, 25, 553-576.
72. Phillips, L. J., Yung, A. R., Hearn, N., et al (1999) Preventive mental health care: accessing the target population. Australian and New Zealand Journal of Psychiatry, 33, 912-917.
73. Phillips, L. J., Velakoulis, D., Pantelis, C., et al (2002a) Non-reduction in hippocampal volume is associated with higher risk of psychosis. Schizophrenia Research, 58, 145-158.
74. Phillips, L. J., Leicester, S. B., O'Dwyer, L. E., et al (2002b) The PACE Clinic: identification and management of young people at 'ultra' high risk of psychosis. Journal of Psychiatric Practice, 8, 255-269.
75. Salokangas, R. K. R., Klosterkotter, J., Birchwood, M., et al (2004) Incidence of patients vulnerable to psychosis: Results of the EPOS project. Schizophrenia Research, 67 (suppl.), 38.
76. Schaffner, K. F. & McGorry, P. D. (2001) Preventing severe mental illnesses: new prospects and ethical challenges. Schizophrenia Research, 51, 3-15.
77. Seidman, L. J., Goldstein, J. M., Goodman, J. M., et al (1997) Sex differences in olfactory identification and Wisconsin card sorting performance in schizophrenia: relationship to attention and verbal ability. Biological Psychiatry, 42, 104-115.
78. van Os, J., Hanssen, M., Bijl, R. V., et al (2000) Strauss (1969) revisited: a psychosis continuum in the general population? Schizophrenia Research, 45, 11-20.
79. van Os, J., Hanssen, M., Bijl, R. V., et al (2001) Prevalence of psychotic disorder and community level of psychotic symptoms: an urban-rural comparison. Archives of General Psychiatry, 58, 663-668.
80. Velakoulis, D., Wood, S. J., McGorry, P. D. & Pantelis, C. (2000) Evidence for progression of brain structural abnormalities in schizophrenia: beyond the neurodevelopmental model. Australian and New Zealand Journal of Psychiatry, 34, s113-s126.
81. Ward, L. C. (1990) Prediction of verbal, performance and full scale IQs from seven subtests of the WAIS-R. Journal of Clinical Psychology, 46, 436-440.
82. Wood, S. J., Pantelis, C., Proffitt, T., et al (2003a) Spatial working memory ability is a marker of risk-for-psychosis. Psychological Medicine, 33, 1239-1247.
83. Wood, S. J., Berger, G., Velakoulis, D., et al (2003b) Proton magnetic resonance spetroscopy in first episode and ultra high-risk individuals. Schizophrenia Bulletin, 29, 831-843.
84. Woods, S.W., Breier, A., Zipursky, R. B., et al (2003) Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome. Biological Psychiatry, 54, 453-464.
85. Wyatt, R. J. & Henter, I. (2001) Rationale for the study of early intervention. Schizophrenia Research, 51, 69-76.
86. Yun, Y., Phillips, L. J., Cotton, S., et al (2005) Obstetric complications and transition to psychosis in an ultra high risk sample. Australian and New Zealand Journal of Psychiatry, in press.
87. Yung, A. R. & McGorry, P. D. (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophrenia Bulletin, 22, 353-370.
88. Yung, A. R. & McGorry, P. D. (2003) Keeping an open mind: investigating options for treatment options of the pre-psychotic phase. Journal of Mental Health, 12, 341-343.
89. Yung, A. R., McGorry, P. D., McFarlane, C. A., et al (1995) The PACE Clinic: development of a clinical service for young people at high risk of psychosis. Australasian Psychiatry, 3, 345-349.
90. Yung, A. R., McGorry, P. D., McFarlane, C. A., et al (1996) Monitoring and care of young people at incipient risk of psychosis. Schizophrenia Bulletin, 22, 283-303.
91. Yung, A. R., Phillips, L. J., McGorry, P. D., et al (1998) Prediction of psychosis. A step towards indicated prevention. British Journal of Psychiatry, 172 (suppl. 33), 14-20.
92. Yung, A. R., Phillips, L. J. & Drew, L. T. (1999) Promoting access to care in early psychosis. In The Recognition and Management of Early Psychosis: A Preventive Approach (eds P. D. McGorry & H. J. Jackson), pp. 81-114. Cambridge, UK: Cambridge University Press.
93. Yung, A. R., Phillips, L. J., Yuen, H. P., et al (2003) Psychosis prediction: 12 month follow-up of a high risk ('prodromal') group. Schizophrenia Research, 60, 21-32.
94. Yung, A. R., Phillips, L. J. & McGorry, P. D. (2004) Treating Schizophrenia in the Prodromal Phase. London: Taylor & Francis.